Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 USD | -19.89% | +7.14% | +62.16% |
May. 02 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 8.59M |
---|---|---|---|---|---|
Net income 2021 | -17M | Net income 2022 | -19M | EV / Sales 2021 | - |
Net cash position 2021 | 23.78M | Net cash position 2022 | 6.72M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.66
x | P/E ratio 2022 |
-0.43
x | Employees | 18 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 84.97% |
Latest transcript on Bellerophon Therapeutics, Inc.
1 day | -21.23% | ||
1 week | +5.36% | ||
Current month | -1.67% | ||
1 month | +4.98% | ||
3 months | +10.69% | ||
6 months | +79.88% | ||
Current year | +59.46% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | - |
Martin Dekker
CTO | Chief Tech/Sci/R&D Officer | 51 | 15-01-28 |
Edwin L. Parsley
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Naseem Amin
CHM | Chairman | 62 | 15-06-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 0.06 | -19.89% | 60 356 |
24-06-07 | 0.0749 | +30.03% | 6,345 |
24-06-06 | 0.0576 | +2.49% | 2,521 |
24-06-05 | 0.0562 | -0.53% | 148 |
24-06-04 | 0.0565 | +0.89% | 4,439 |
Delayed Quote OTC Markets, June 10, 2024 at 10:07 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+59.46% | 916K | |
+18.10% | 125B | |
+13.29% | 108B | |
-7.45% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.38% | 16.37B | |
+0.93% | 13.58B | |
+27.63% | 11.66B |
- Stock Market
- Equities
- BLPH Stock